Comparison of liver histology and fibrosis-4 scoring as tools for evaluating healthcare resource utilization and costs in patients with MASLD: a Swedish cohort study
These data highlight the positive association between fibrosis severity and HCRU and costs in MASLD, and suggest that FIB-4 may have similar utility to biopsy for evaluating certain HCRU outcomes.
Authors
- Stergios Kechagias (ORCID: https://orcid.org/0000-0001-7614-739X)
- Mette Winther (ORCID: https://orcid.org/0000-0001-9814-4448)
- Kamal Kant Mangla (ORCID: https://orcid.org/0000-0002-3613-2748)
- Johan Vessby (ORCID: https://orcid.org/0000-0003-1638-1023)
- Ying Shang (ORCID: https://orcid.org/0000-0002-1496-1799)
- Helena Skröder (ORCID: https://orcid.org/0000-0001-8318-7445)
- Emilie Toresson Grip (ORCID: https://orcid.org/0000-0002-2630-9503)
- Hannes Hagström (ORCID: https://orcid.org/0000-0002-8474-1759)
- Riku Ota (ORCID: https://orcid.org/0000-0002-6379-4376)
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Novo Nordisk (Denmark) (DK)
- Karolinska Institutet (SE)
- Department of Medical Sciences (RU)
- Quantify Research (Sweden) (SE)
- Novo Nordisk (India) (IN)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1080/00365521.2025.2553284
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35